loadpatents
name:-0.013801097869873
name:-0.015563011169434
name:-0.0016598701477051
Lavergne; Olivier Patent Filings

Lavergne; Olivier

Patent Applications and Registrations

Patent applications and USPTO patent grants for Lavergne; Olivier.The latest application filed is for "macrocyclic lrrk2 kinase inhibitors".

Company Profile
1.16.17
  • Lavergne; Olivier - Palaiseau FR
  • LAVERGNE; Olivier - Palaiseua FR
  • Lavergne; Olivier - Massy FR
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Macrocyclic LRRK2 kinase inhibitors
Grant 10,377,772 - Hoflack , et al. A
2019-08-13
Macrocyclic Lrrk2 Kinase Inhibitors
App 20170240565 - Hoflack; Jan ;   et al.
2017-08-24
Substituted biphenyl analogues as dual inhibitors of aromatase and sulfatase
Grant 9,682,941 - Auvin , et al. June 20, 2
2017-06-20
New Substituted Biphenyl Analogues As Dual Inhibitors Of Aromatase And Sulfatase
App 20170001964 - AUVIN; Serge ;   et al.
2017-01-05
Macrocyclic LRRK2 Kinase Inhibitors
App 20160031905 - HOFLACK; Jan ;   et al.
2016-02-04
Imidazolidine-2,4-dione derivatives, and use thereof as a cancer drug
Grant 8,710,091 - Prevost , et al. April 29, 2
2014-04-29
Imidazolidine-2,4-dione Derivatives, And Use Thereof As A Cancer Drug
App 20120083514 - Prevost; Gregoire ;   et al.
2012-04-05
Pyrazolo-pyrazines Derivatives Used As G Protein Inhibitors
App 20100222332 - Lavergne; Olivier ;   et al.
2010-09-02
Benzooxazole-4,7-dione, Derivatives And Their Use As Cdc25 Phosphate Inhibitors
App 20090131428 - Galcera Contour; Marie-Odile ;   et al.
2009-05-21
Benzothiazole- And Benzooxazole-4,7-dione, Derivatives And Their Use As Cdc25 Phosphate Inhibitors
App 20090082345 - GALCERA CONTOUR; Marie-Odile ;   et al.
2009-03-26
Benzothiazole- and benzooxazole-4,7-dione, derivatives and their use as cdc25 phosphate inhibitors
Grant 7,495,021 - Galcera Contour , et al. February 24, 2
2009-02-24
Benzothiazole-4,7-diones and benzoxazole-4,7-diones with substituents in position 5 or 6 and method for production thereof
Grant 7,335,674 - Galcera Contour , et al. February 26, 2
2008-02-26
Benzothiazole- And Benzooxazole-4,7-dione, Derivatives And Their Use As Cdc25 Phosphate Inhibitors
App 20070255063 - Galcera Contour; Marie-Odile ;   et al.
2007-11-01
Benzothiazole-and benzoxazole-4, 7-dione derivatives and their use as dcd25 phosphatase inhibitors
Grant 7,279,467 - Galcera Contour , et al. October 9, 2
2007-10-09
Analogues of camptothecin, their use as medicaments and the pharmaceutical compositions containing them
Grant 7,135,478 - Bigg , et al. November 14, 2
2006-11-14
Benzothiazole-4,7-diones and benzoxazole-4,7-diones with substituents in position 5 or 6 and method for production thereof
App 20060135573 - Galcera Contour; Marie-Odile ;   et al.
2006-06-22
Analogues of camptothecin, their use as medicaments and the pharmaceutical compositions containing them
Grant 7,053,102 - Bigg , et al. May 30, 2
2006-05-30
Optically pure camptothecin analogues
Grant 7,012,079 - Lavergne , et al. March 14, 2
2006-03-14
Benzothiazole-and benzoxazole-4, 7-dione derivatives and their use as dcd25 phosphatase inhibitors
App 20060040996 - Galcera Contour; Marie-Odile ;   et al.
2006-02-23
Mikanolide derivatives, their preparation and therapeutic uses
Grant 6,887,869 - Lavergne , et al. May 3, 2
2005-05-03
New analogues of camptothecin, their use as medicaments and the pharmaceutical compositions containing them
App 20050038064 - Bigg, Dennis ;   et al.
2005-02-17
New analogues of camptothecin, their use as medicaments and the pharmaceutical compositions containing them
App 20040254163 - Bigg, Dennis ;   et al.
2004-12-16
Analogues of camptothecin, their use as medicaments and the pharmaceutical compositions containing them
Grant 6,815,546 - Bigg , et al. November 9, 2
2004-11-09
Analogues of camptothecin, their use as medicaments and the pharmaceutical compositions containing them
Grant 6,797,715 - Bigg , et al. September 28, 2
2004-09-28
Product comprising mikanolide, dihydromikanolide or an analogue thereof combine with another anti-cancer agent for therapeutic use in cancer treatment
App 20040138245 - Prevost, Gregoire ;   et al.
2004-07-15
Analogues of camptothecin, their use as medicaments and the pharmaceutical compositions containing them
Grant 6,762,301 - Bigg , et al. July 13, 2
2004-07-13
Mikanolide derivatives, their preparation and therapeutic uses
App 20040122084 - Lavergne, Olivier ;   et al.
2004-06-24
Tetracyclic analogues of camptothecins, their preparation processes, their use as medicaments and the pharmaceutical compositions containing them
Grant 6,632,946 - Bigg , et al. October 14, 2
2003-10-14
New analogues of camptothecin, their use as medicaments and the pharmaceutical compositions containing them
App 20030004150 - Bigg, Dennis ;   et al.
2003-01-02
New analogues of camptothecin, their use as medicaments and the pharmaceutical compositions containing them
App 20020160994 - Bigg, Dennis ;   et al.
2002-10-31
Comptothecin analogues, preparation methods therefor, use thereof as drugs, and pharmaceutical compositions containing said analogues
Grant 6,339,091 - Bigg , et al. January 15, 2
2002-01-15
New tetracyclic analogues of camptothecins, their preparation processes, their use as medicaments and the pharmaceutical compositions containing them
App 20010000521 - Bigg, Dennis ;   et al.
2001-04-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed